YDS Pharmatech, Inc., a techbio startup revolutionizing drug design with its low-data-dependent AI solutions, is proud to present its latest innovations at Biotech Showcase™ 2023. YDS is leveraging the power of biophysics simulation-informed AI to create smarter, more effective drug design solutions. Come join us and experience the future of drug design!
Join us on Wednesday, January 11, 2023 at 4:30 PM PST for an exciting presentation at the luxurious Hilton San Francisco – Union Square! Located at 333 O’Farrell Street, the event will take place in the Ballroom Level’s Franciscan D. Get ready to be captivated by the insights and information that will be shared in this exclusive event!
At YDS, we are passionate about transforming the landscape of drug discovery through computational solutions. Our MERES® platform is revolutionizing the way molecules are designed to meet desired properties. To date, we have already contributed new intellectual property to our partners on three difficult targets and are actively advancing six more drug discovery projects. Our AI-accelerated molecular simulation system is one of the keys to our success, as it accurately predicts protein dynamics changes when a ligand binds to the protein. We are proud to be leading the way in drug discovery and are excited to see what the future holds.
We are thrilled to welcome YDS Pharmatech, Inc. to join us in beautiful San Francisco for Biotech Showcase. This exclusive event offers life science entrepreneurs and investors a prime opportunity to explore the exciting potential of cutting-edge technologies that will shape the future of drug discovery. Don’t miss out!
About YDS Pharmatech
YDS Pharmatech is a cutting-edge drug design company located in Albany, NY that is revolutionizing how drug discovery is conducted. Our proprietary AI and biophysics-based drug design engine, MERES® (Modify-Evaluate-Reinforce-Evolve-Sampling), provides an efficient and directed exploration of the chemical space. With MERES®, drug discovery is no longer a random process, but a targeted search for the best possible drug design. For more information, please visit yds-pharmatech.com, and follow us on LinkedIn.
YDS Pharmatech’s revolutionary MERES® drug design engine uses a combination of AI, biophysics, and statistical mechanics to generate novel drug candidate molecules with the desired properties from a single input molecule. This powerful platform allows us to make the leap from serendipitous drug discovery to rational, structure-based design, with its ternary co-folding computation sub-platform modeling how different molecular glues can regulate CRBN conformations and bring about PROTAC-induced ternary structures. Unlocking the potential of this technology is revolutionizing the drug discovery process.